We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

147 hedge funds and large institutions have $1.9B invested in Harmony Biosciences in 2021 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

329% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 14

60% more capital invested

Capital invested by funds: $1.19B → $1.9B (+$714M)

44% more funds holding

Funds holding: 102 → 147 (+45)

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

29% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 31

21.95% more ownership

Funds ownership: 54.26% → 76.21% (+22%)

Holders
147
Holders Change
+45
Holders Change %
+44.12%
% of All Funds
2.26%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
60
Increased
40
Reduced
31
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$84.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$20.3M
3
State Street
State Street
Massachusetts
+$15.1M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.9M
5
American Century Companies
American Century Companies
Missouri
+$11.4M

Top Sellers

Rank Fund Capital Flow
1
NP
Newlight Partners
New York
-$39.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$17.6M
3
VP
venBio Partners
California
-$12.9M
4
PA
Perceptive Advisors
New York
-$10M
5
ACM
Aisling Capital Management
New York
-$9.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
126
Osaic Holdings
Arizona
$28K +$19.1K +479 +352%
TRCT
127
Tower Research Capital (TRC)
New York
$21K +$1.51K +38 +9%
SGAM
128
Smith Group Asset Management
Texas
$17K – – –
EVM
129
Eaton Vance Management
Massachusetts
$16K +$14.6K +366 New
LSA
130
Leonteq Securities AG
Switzerland
$15.8K +$14.7K +370 New
Ensign Peak Advisors
131
Ensign Peak Advisors
Utah
$12K +$11.6K +290 New
CAPTRUST Financial Advisors
132
CAPTRUST Financial Advisors
North Carolina
$8K +$6.82K +171 +1,900%
Daiwa Securities Group
133
Daiwa Securities Group
Japan
$7K +$6.82K +171 New
Nisa Investment Advisors
134
Nisa Investment Advisors
Missouri
$6K -$9.69K -243 -58%
Bessemer Group
135
Bessemer Group
New Jersey
$4K – – –
TWA
136
TCI Wealth Advisors
Arizona
$3K – – –
Fifth Third Bancorp
137
Fifth Third Bancorp
Ohio
$3K +$2.47K +62 New
PFBT
138
Parkside Financial Bank & Trust
Missouri
$3K +$3.03K +76 New
MPWT
139
MassMutual Private Wealth & Trust
Connecticut
$2K +$558 +14 +58%
NFSG
140
Newbridge Financial Services Group
Florida
$1K – – –
C
141
Covestor
United Kingdom
$1K +$797 +20 New
MAM
142
Meeder Asset Management
Ohio
$1K +$1.31K +33 New
Manulife (Manufacturers Life Insurance)
143
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$511 +$19.9K +500 +4%
Balyasny Asset Management
144
Balyasny Asset Management
Illinois
– -$3.92M -102,292 Closed
LP
145
LMR Partners
United Kingdom
– -$3.83M -100,000 Closed
CI
146
Cambiar Investors
Colorado
– -$3.15M -82,222 Closed
GTC
147
Ghost Tree Capital
New York
– -$2.88M -75,000 Closed
NHAS
148
Novo Holdings A/S
Denmark
– -$1.53M -40,000 Closed
Verition Fund Management
149
Verition Fund Management
Connecticut
– -$1.07M -27,799 Closed
Vontobel Holding
150
Vontobel Holding
Switzerland
– -$383K -10,000 Closed
3 4 5
6
7

HRMY Hedge Fund Activity: Q4 2021 in Review

147 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q4 2021, worth a combined $1.9B — up 60% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new HRMY positions and 14 closed out — a net gain of 46 holders — while 40 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $84.7M. The largest seller was Newlight Partners, cutting an estimated $39.9M.

  • 147 institutional investors held Harmony Biosciences (HRMY) as of Q4 2021, up from 102 in Q3 2021.
  • Funds reported $1.9B of Harmony Biosciences stock for Q4 2021, up 60% quarter-over-quarter.
  • 60 funds opened new Harmony Biosciences positions in Q4 2021 and 14 closed out, a net change of +46 holders.
  • The largest Harmony Biosciences buyer in Q4 2021 was BlackRock, an estimated $84.7M added.
  • The largest Harmony Biosciences seller in Q4 2021 was Newlight Partners, an estimated $39.9M sold.

Based on aggregated 13F filings for Q4 2021.